Stock CC THE CHEMOURS COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Chemours Company

Equities

CC

US1638511089

Diversified Chemicals

Market Closed - Nyse
Other stock markets
 16:00:02 2024-04-26 EDT 		5-day change 1st Jan Change
27.32 USD +1.07% Intraday chart for The Chemours Company +5.44% -13.38%
04-26 Well, it isn't as bad as feared... Our Logo
04-26 Chemours CFO Jonathan Lock steps down after financial revisions RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,958 4,078 5,469 4,621 4,682 4,067 - -
Enterprise Value (EV) 1 6,175 6,999 7,767 7,134 7,517 7,143 7,044 7,257
P/E ratio -56.5 x 18.8 x 9.32 x 8.39 x -19.7 x 16.7 x 7.78 x 5.17 x
Yield 5.53% 4.03% 2.98% 3.27% - 3.75% 3.85% 4.26%
Capitalization / Revenue 0.54 x 0.82 x 0.86 x 0.68 x 0.78 x 0.69 x 0.63 x 0.62 x
EV / Revenue 1.12 x 1.41 x 1.22 x 1.05 x 1.25 x 1.22 x 1.09 x 1.1 x
EV / EBITDA 6.05 x 7.96 x 5.92 x 5.24 x 7.41 x 7.69 x 5.85 x 5.28 x
EV / FCF 36.5 x 13 x 14.3 x 16 x 40.4 x -33.2 x 26.1 x 13.8 x
FCF Yield 2.74% 7.72% 6.99% 6.27% 2.47% -3.01% 3.83% 7.27%
Price to Book 4.29 x 5.03 x 5 x 4.11 x 6.36 x 37.4 x 16.7 x 7.67 x
Nbr of stocks (in thousands) 163,501 164,496 162,961 150,918 148,438 148,881 - -
Reference price 2 18.09 24.79 33.56 30.62 31.54 27.32 27.32 27.32
Announcement Date 20-02-13 21-02-11 22-02-10 23-02-09 24-03-27 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,526 4,969 6,345 6,794 6,027 5,854 6,435 6,570
EBITDA 1 1,020 879 1,313 1,361 1,014 928.5 1,203 1,376
EBIT 1 709 559 996 1,070 707 588.1 889.7 1,030
Operating Margin 12.83% 11.25% 15.7% 15.75% 11.73% 10.05% 13.83% 15.68%
Earnings before Tax (EBT) 1 - - - 741 - 305 657 986
Net income 1 -52 - 608 578 -238 247 532 799
Net margin -0.94% - 9.58% 8.51% -3.95% 4.22% 8.27% 12.16%
EPS 2 -0.3200 1.320 3.600 3.650 -1.600 1.640 3.510 5.280
Free Cash Flow 1 169 540 543 447 186 -215.3 270 527.3
FCF margin 3.06% 10.87% 8.56% 6.58% 3.09% -3.68% 4.2% 8.03%
FCF Conversion (EBITDA) 16.57% 61.43% 41.36% 32.84% 18.34% - 22.44% 38.33%
FCF Conversion (Net income) - - 89.31% 77.34% - - 50.75% 66%
Dividend per Share 2 1.000 1.000 1.000 1.000 - 1.025 1.052 1.165
Announcement Date 20-02-13 21-02-11 22-02-10 23-02-09 24-03-27 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,680 1,575 1,764 1,915 1,777 1,338 1,536 1,643 1,487 1,361 1,410 1,593 1,577 1,430 1,522
EBITDA 1 372 307 403 475 363 120 304 324 247 176 160 264.8 261 212.6 282.7
EBIT 1 294 231 329 403 291 46 225 246 171 102 84.06 216.5 187 143.5 233.3
Operating Margin 17.5% 14.67% 18.65% 21.04% 16.38% 3.44% 14.65% 14.97% 11.5% 7.49% 5.96% 13.59% 11.86% 10.03% 15.33%
Earnings before Tax (EBT) 1 - - - 231 299 - 173 -433 - -71 16 117 115 57 113
Net income 1 214 233 234 201 240 -97 145 -376 - -18 13 95 93 46 91
Net margin 12.74% 14.79% 13.27% 10.5% 13.51% -7.25% 9.44% -22.88% - -1.32% 0.92% 5.96% 5.9% 3.22% 5.98%
EPS 2 1.270 1.400 1.430 1.260 1.520 -0.6500 0.9600 -2.520 - -0.1200 0.0900 0.6200 0.6100 0.3000 0.5900
Dividend per Share 2 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 - 0.2500 0.2500 0.2500 0.2500 -
Announcement Date 21-11-04 22-02-10 22-05-02 22-07-28 22-10-25 23-02-09 23-04-27 23-07-28 23-10-26 24-03-27 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,217 2,921 2,298 2,513 2,835 3,075 2,976 3,190
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.154 x 3.323 x 1.75 x 1.846 x 2.796 x 3.312 x 2.473 x 2.319 x
Free Cash Flow 1 169 540 543 447 186 -215 270 527
ROE (net income / shareholders' equity) 49.2% 43.8% 64.2% 67.5% 46.1% 46.9% 143% 96.5%
ROA (Net income/ Total Assets) 5.73% 4.59% 8.31% 9.72% 5.35% 3.85% 5.57% 6.75%
Assets 1 -907.2 - 7,316 5,948 -4,449 6,412 9,548 11,844
Book Value Per Share 2 4.210 4.930 6.710 7.450 4.960 0.7300 1.640 3.560
Cash Flow per Share 2 3.940 - 4.860 4.760 3.690 0.5000 2.060 4.800
Capex 1 481 267 277 307 370 438 447 403
Capex / Sales 8.7% 5.37% 4.37% 4.52% 6.14% 7.49% 6.94% 6.14%
Announcement Date 20-02-13 21-02-11 22-02-10 23-02-09 24-03-27 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for The Chemours Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
27.32 USD
Average target price
31.27 USD
Spread / Average Target
+14.46%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
THE CHEMOURS COMPANY Stock The Chemours Company
-13.38% 4.07B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.19% 74.89B
BASF SE Stock BASF SE
+0.09% 46.52B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-4.19% 30.82B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.85% 18.19B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.54B
SYENSQO SA/NV Stock Syensqo SA/NV
-8.09% 9.73B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+2.79% 9.4B
SRF LIMITED Stock SRF Limited
+6.35% 9.37B
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
+3.85% 8.11B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. CC Stock
  4. Financials The Chemours Company